Radio active Iodine in Thyroid Cancer

Q) Which of the following is not true about Radioactive Iodine (RAI) use in thyroid cancer? (Thyroid onco) 

a) Screening with RAI  is less sensitive than Thyroglobulin estimation in most differentiated thyroid cancers for detecting metastasis

b) Metastatic differentiated thyroid carcinoma can be detected by  131I in about 50% of patients

c) Current guidelines s recommend RAI after total thyroidectomy only for patients with known distant metastases

d) Hurthle cell cancer des not take up RAI

 

Bladder Cancer

Q) What is the most suitable treatment option for non muscle-invasive bladder cancer with the risk of recurrences?

A)Cystectomy

B)Intravesical chemotherapy

C)Transurethral resection and adjuvant intravesical chemotherapy

D)Palliative therapy

Answer-C(Schwartz-1654)

Patients with non–muscle-invasive bladder cancer (confined to the bladder mucosa or submucosa) can be managed with transurethral resection alone and adjuvant intravesical (instilled into the bladder) chemotherapy/immunotherapy.

The use of these intravesical agents is critical since patients with non–muscle-invasive bladder cancer are at risk for tumour recurrence and progression.

 

Uro Onco MCQS

error: Content is protected !!